Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Melphalan × Breast × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 5 Myeloid 4 Lymphoid 4 Plasma cell 3 Dermatologic 3 Sarcoma 2 Other neoplasm 2 Gastrointestinal 2 Endocrine 1 Classical hematology 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 15 Inflammatory Breast Neoplasms 3 Breast Neoplasms, Male 3 Recurrence 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Muscle Neoplasms 1

Interventions

Paclitaxel 24 pembrolizumab 21 Docetaxel 19 Capecitabine 18 Trastuzumab 16 Fulvestrant 14 Cyclophosphamide 13 Lapatinib 12 Carboplatin 10 Anastrozole 10 Therapeutics 9 Radiotherapy 9 Letrozole 8 Cisplatin 8 Nivolumab 7 Gemcitabine 7 Exercise 7 Doxorubicin 7 Blood Specimen Collection 7 Bevacizumab 7 palbociclib 6 liposomal doxorubicin 6 Vinorelbine 6 Fluorouracil 6 atezolizumab 5 Tamoxifen 5 Methods 5 Irinotecan 5 Denosumab 5 Cetuximab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06154590 2023-12-04

NASBP-B-09

Paradyne Networks A Foundation

Not yet recruiting

Breast Neoplasms, Neoplasms, Muscle Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡